Local and Systemic Changes in Osteonecrosis of the Jawbone — SULVO

Osteonecrosis of the Jaw Clinical Trial

Official title:
Pilot Study: Local and Systemic Changes in Osteonecrosis of the Jawbone

Status Enrolling by invitation

Clinical Trial Summary

Osteonecrosis of the Jawbone (ONJ) is a serious complication of antiresorptive therapies (ARTs), for example with bisphosphonates or Denosumab. Especially long term treatment with intravenous antiresorptive agents causing lesions and, less frequent, also oral administration. This study aims at elucidating local and systemic changes in patients with ONJ.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05329558
Study type	Observational
Source	Medical University of Graz
Contact
Status	Enrolling by invitation
Phase
Start date	March 1, 2018
Completion date	December 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01666106` - Osteonecrosis of the Jaw (ONJ) Case Registry
Not yet recruiting	`NCT06419010` - Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw	N/A
Completed	`NCT01201330` - DPBRN Retrospective Cohort Study of Osteonecrosis of the Jaw	N/A
Completed	`NCT01130389` - CONDOR Study of Osteonecrosis of the Jaws (TMJ)	N/A
Completed	`NCT01967160` - Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid
Recruiting	`NCT06457776` - Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs